Alira Health Welcomes Richard Charter, Vice President, Market Access, MedTech, Europe & Asia-Pacific

News
Published on:
April 23, 2020

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, welcomes Richard Charter as Vice President, Market Access, MedTech, Europe & Asia-Pacific to our office in Basel, Switzerland. Richard brings extensive experience in the MedTech industry and a comprehensive background in both financial and health economics to our Market Access Team.

At Alira Health, our aim is to become the number one market access MedTech player in the EU and U.S. by 2023. Richard’s vast experience and ability to create value for our customers and partners will help us to reach this goal and strengthen our commitment to a segment that is often overlooked for its size and complexity,” said Jean-François Ricci, Executive Vice President, Global Market Access, Alira Health. “Richard will lead Alira Health’s experienced MedTech Market Access Team in the EU, pioneer new MedTech specific methodologies and tools, and drive partnerships with the most important associations and academic institutions in the world to enable healthcare transformation for our MedTech clients.”

I am thrilled to join Alira Health’s senior leadership and join Jean-François and the Global Market Access Team in Basel, Switzerland,” said Richard. “This represents a fantastic opportunity to take Alira Health’s existing medical technology capabilities in product development, clinical trial development, and regulatory affairs, and further expand our MedTech market access capabilities. These capabilities are critical for successful product launch and payer/provider engagement. This team can deliver unparalleled solutions for our clients and lead MedTech Market Access globally.”

Richard brings over 15 years of experience in financial and health economics across multiple sectors, including financial services and healthcare. Richard has focused exclusively on the MedTech market access space, including leading the market access and pricing functions at a major medical device company.

Currently, Richard is the Co-chair of the ISPOR Medical Device Special Interest Group and Co-chair of the HTAi Medical Device Interest Group, the industry advisor to the EU-funded Horizon 2020 COMED initiative on cost and outcomes measurement for medical devices (COMED). Previously, Richard was the Chairperson of the MedTech Europe Evidence & Payers Working Group and core contributor to the Value-Based Procurement Working Group.

To learn more about our team

Click here

Related news

Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
Multimedia June 21, 2022
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
Genomic Testing Market Access MedTech
Publications May 27, 2022
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
CDMO MedTech Robotcs
News May 11, 2022
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
MedTech Patient Engagement Pharma
Multimedia May 10, 2022
VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development
Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)
Market Access
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Uncategorized May 6, 2022
U.S. and European Clinical Development for Asian MedTech Startups
This webinar will focus on the U.S. FDA and EU MDR/IVDR regulatory pathways and strategies for medical device startups based in the Asia Pacific.
Clinical MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.